ArticleEndocrine2026
Hormonal and metabolic profiles in teenagers and young adults with polycystic ovary syndrome (PCOS).
Article in Endocrine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate metabolic and hormonal profile in teenagers and young adults with PCOS.
methodsIn this case-control study, conducted from Jan 2023 and Feb 2025, we enrolled adolescents (below 20 years of age) and young adults (≤ 25 yrs) with PCOS. The assessment of glucose and insulin (Ins) in oral glucose tolerance test (OGTT) along with lipid profile and hormonal variables including free androgen index (FAI), total testosterone (TT), sex-hormone binding globulin (SHBG) and dehydroepiandrosterone sulfate (DHEA-S]) was performed among these women.
resultsBoth teenagers and young adults with PCOS and with FAI > 5 showed unfavorably changed metabolic profile reflected by higher Ins levels in OGTT along with lower high-density lipoprotein cholesterol (HDL-C) levels in contrary to the remaining group. Adolescents and young adults with overweight/obesity showed insulin resistants reflected by HOMA-IR (4.45 and 4.26, respectively) compared to women with PCOS and with BMI within ranges (1.68 and 1.89, respectively, all p < 0.05). Teenagers with higher BMI showed unfavourable lipid profile reflected by higher triglycerides (TS) and lower HDL-C. Regarding hormonal profile, overweight/obesity was related to increased FAI in teenagers and lower SHBG and DHEA-S in young adults.
conclusionBoth adolescents and young women with PCOS represent unfavorable metabolic profile related to elevated FAI and higher BMI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.